about
Pediatric Nephrology in Primary Care: The Forest for the Trees.Safety and tolerability of autologous bone marrow mesenchymal stromal cells in ADPKD patients.Why does quality of life remain an under-investigated issue in chronic kidney disease and why is it rarely set as an outcome measure in trials in this population?Association between syndecan-1 and renal function in adolescents with excess weight: evidence of subclinical kidney disease and endothelial dysfunction.
P2860
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年学术文章
@wuu
2015年学术文章
@zh-cn
2015年学术文章
@zh-hans
2015年学术文章
@zh-my
2015年学术文章
@zh-sg
2015年學術文章
@yue
2015年學術文章
@zh
2015年學術文章
@zh-hant
name
Biomarkers and surrogate endpoints in kidney disease.
@ast
Biomarkers and surrogate endpoints in kidney disease.
@en
type
label
Biomarkers and surrogate endpoints in kidney disease.
@ast
Biomarkers and surrogate endpoints in kidney disease.
@en
prefLabel
Biomarkers and surrogate endpoints in kidney disease.
@ast
Biomarkers and surrogate endpoints in kidney disease.
@en
P2860
P1433
P1476
Biomarkers and surrogate endpoints in kidney disease.
@en
P2860
P2888
P304
P356
10.1007/S00467-015-3104-8
P50
P577
2015-05-16T00:00:00Z